Published in J Allergy Clin Immunol on October 01, 2004
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
Oral and nasal sensitization promote distinct immune responses and lung reactivity in a mouse model of peanut allergy. Am J Pathol (2005) 0.94
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.94
Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway. J Allergy Clin Immunol (2010) 0.91
The immunology of food allergy. J Immunol (2014) 0.83
The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis. J Allergy Clin Immunol (2013) 0.82
Therapeutic effects of a fermented soy product on peanut hypersensitivity is associated with modulation of T-helper type 1 and T-helper type 2 responses. Clin Exp Allergy (2008) 0.79
CD4-blockade can induce protection from peanut-induced anaphylaxis. Front Immunol (2011) 0.79
Diacylglycerol kinase ζ deficiency in a non-CD4(+) T-cell compartment leads to increased peanut hypersensitivity. J Allergy Clin Immunol (2011) 0.78
Determinants of food allergy. Immunol Allergy Clin North Am (2012) 0.78
Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. Mol Nutr Food Res (2013) 0.77
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Oral immunotherapy for treatment of egg allergy in children. N Engl J Med (2012) 5.19
Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol (2007) 4.25
Food allergy. J Allergy Clin Immunol (2009) 4.05
US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol (2010) 3.99
Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91
Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol (2010) 3.49
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol (2008) 3.19
National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol (2010) 3.12
Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol (2003) 3.06
Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol (2006) 3.03
Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med (2003) 3.00
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77
9. Food allergy. J Allergy Clin Immunol (2006) 2.72
X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) (2006) 2.66
ICON: food allergy. J Allergy Clin Immunol (2012) 2.65
The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol (2010) 2.52
Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol (2010) 2.50
Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol (2008) 2.41
Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. J Trauma Acute Care Surg (2012) 2.28
Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol (2008) 2.24
Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol (2007) 2.22
Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J (2010) 2.07
Future therapies for food allergies. J Allergy Clin Immunol (2011) 2.04
The changing CARE for patients with food allergy. J Allergy Clin Immunol (2013) 2.04
Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol (2009) 1.98
Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants. J Allergy Clin Immunol (2010) 1.97
The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol (2012) 1.96
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
Preventing peanut allergy through early consumption--ready for prime time? N Engl J Med (2015) 1.91
Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol (2004) 1.90
Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol (2008) 1.86
Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2007) 1.85
Dietary intake in the lower Mississippi delta region: results from the Foods of our Delta Study. J Am Diet Assoc (2004) 1.84
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol (2011) 1.81
The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol (2006) 1.79
Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol (2011) 1.79
The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol (2005) 1.77
Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab (2009) 1.75
Outcomes of office-based, open food challenges in the management of food allergy. J Allergy Clin Immunol (2011) 1.71
Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children. J Allergy Clin Immunol (2009) 1.69
Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol (2004) 1.68
Food allergen sensitization in inner-city children with asthma. J Allergy Clin Immunol (2005) 1.67
Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol (2002) 1.67
Allergenicity assessment of genetically modified crops--what makes sense? Nat Biotechnol (2008) 1.67
A global survey of changing patterns of food allergy burden in children. World Allergy Organ J (2013) 1.66
Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol (2009) 1.66
Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol (2009) 1.60
Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60
Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med (2009) 1.59
Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol (2007) 1.57
AskHERMES: An online question answering system for complex clinical questions. J Biomed Inform (2011) 1.57
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol (2012) 1.56
The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population. BMC Pulm Med (2009) 1.53
Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol (2009) 1.53
Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy. J Allergy Clin Immunol (2011) 1.52
The influence of genetic variation in surfactant protein B on severe lung injury in African American children. Crit Care Med (2011) 1.52
Hypoallergenicity and effects on growth and tolerance of a new amino acid-based formula with docosahexaenoic acid and arachidonic acid. J Pediatr (2008) 1.51
Association between rainfall and pediatric emergency department visits for acute gastrointestinal illness. Environ Health Perspect (2010) 1.50
Food supply adequacy in the Lower Mississippi Delta. J Nutr Educ Behav (2007) 1.50
Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol (2009) 1.50
Vasopressin for in-hospital pediatric cardiac arrest: results from the American Heart Association National Registry of Cardiopulmonary Resuscitation. Pediatr Crit Care Med (2009) 1.49
The natural progression of peanut allergy: Resolution and the possibility of recurrence. J Allergy Clin Immunol (2003) 1.49
Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg (2009) 1.49
Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics (2012) 1.48
Association of cystic fibrosis transmembrane conductance regulator gene variants with acute lung injury in African American children with pneumonia*. Crit Care Med (2012) 1.46
Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics (2003) 1.45
Sentinel injuries in infants evaluated for child physical abuse. Pediatrics (2013) 1.42
Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells. J Allergy Clin Immunol (2009) 1.41
Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy. Pediatr Allergy Immunol (2014) 1.41
Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol (2008) 1.39
Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol (2010) 1.37
Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology. Clin Chem Lab Med (2005) 1.37
Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts. J Allergy Clin Immunol (2003) 1.35
Recruitment of Hispanic women to the Women's Health Initiative. the case of Embajadoras in Arizona. Control Clin Trials (2002) 1.35
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res (2002) 1.34
IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol (2005) 1.33
Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol (2008) 1.33
Significance of ovomucoid- and ovalbumin-specific IgE/IgG(4) ratios in egg allergy. J Allergy Clin Immunol (2012) 1.32
Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Ann Allergy Asthma Immunol (2010) 1.31
A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol (2010) 1.30
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol (2011) 1.30
Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics (2003) 1.30